Rhythm Pharmaceuticals (RYTM) Stock Chart & Stock Price History $56.07 -1.67 (-2.89%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$55.34 -0.73 (-1.29%) As of 02/21/2025 06:06 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Rhythm Pharmaceuticals Stock Price Performance 5 Day Performance-1.09%1 Month Performance-2.03%3 Month Performance-6.46%6 Month Performance+26.88%Year-To-Date Performance+0.16%1 Year Performance+27.26% Receive RYTM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Rhythm Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address RYTM Stock Chart for Saturday, February, 22, 2025 RYTM Chart by TradingView Rhythm Pharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization02/21/2025$57.74$56.07-2.89%$58.45$55.99420,178 shs$3.45 billion02/20/2025$58.00$57.74-0.45%$58.39$56.64266,669 shs$3.55 billion02/19/2025$57.55$58.00+0.78%$58.24$56.61374,320 shs$3.56 billion02/18/2025$56.69$57.55+1.52%$57.73$56.03419,859 shs$3.54 billion02/17/2025$56.69$56.69$58.46$56.56327,086 shs$3.48 billion02/14/2025$57.56$56.69-1.51%$58.46$56.56327,086 shs$3.48 billion02/13/2025$57.64$57.56-0.14%$58.65$56.87298,610 shs$3.54 billion02/12/2025$57.58$57.64+0.10%$57.70$55.72276,829 shs$3.54 billion02/11/2025$58.47$57.58-1.52%$58.16$57.16289,541 shs$3.54 billion02/10/2025$59.18$58.47-1.20%$59.98$57.98388,811 shs$3.64 billion Get the Latest News and Ratings for RYTM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Rhythm Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 02/07/2025$60.01$59.18-1.38%$60.10$58.65372,997 shs$3.64 billion02/06/2025$61.02$60.01-1.66%$60.84$59.11361,332 shs$3.69 billion02/05/2025$59.95$61.02+1.78%$62.14$59.78648,641 shs$3.75 billion02/04/2025$59.41$59.95+0.91%$60.14$58.49441,491 shs$3.68 billion02/03/2025$59.43$59.41-0.03%$60.48$57.67639,161 shs$3.65 billion01/31/2025$59.22$59.43+0.35%$60.69$58.80418,034 shs$3.65 billion01/30/2025$57.19$59.22+3.55%$59.50$57.55294,253 shs$3.64 billion01/29/2025$56.81$57.19+0.67%$57.56$56.47274,784 shs$3.51 billion01/28/2025$56.42$56.81+0.70%$57.72$55.14544,383 shs$3.49 billion01/27/2025$57.78$56.42-2.36%$59.03$56.27371,180 shs$3.47 billion01/24/2025$58.47$57.78-1.18%$58.49$56.89348,242 shs$3.55 billion01/23/2025$57.23$58.47+2.17%$58.64$56.04364,819 shs$3.59 billion01/22/2025$57.52$57.23-0.50%$57.61$56.27345,131 shs$3.52 billion01/21/2025$54.54$57.52+5.46%$57.58$55.001.15 million shs$3.54 billion Related Companies Intra-Cellular Therapies Stock Chart Viatris Stock Chart Genmab A/S Stock Chart Moderna Stock Chart Dr. Reddy's Laboratories Stock Chart Sarepta Therapeutics Stock Chart Vaxcyte Stock Chart Qiagen Stock Chart Roivant Sciences Stock Chart Ascendis Pharma A/S Stock Chart Receive RYTM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Rhythm Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:RYTM) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredBITCOINDid you miss out on the 1000%+ gains of Bitcoin over the past 5 years? If so, you don't want to miss this.....Awesomely, LLC | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rhythm Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rhythm Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
